메뉴 건너뛰기




Volumn 49, Issue 2, 2014, Pages 85-94

Hypercoagulable states: An algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants

Author keywords

Algorithmic approach; Antiphospholipid syndrome; Direct oral anticoagulant; Hypercoagulability; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; B2GP1 PROTEIN ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN ANTIBODY; PROTHROMBIN; UNCLASSIFIED DRUG;

EID: 84903550313     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2014.49.2.85     Document Type: Review
Times cited : (62)

References (78)
  • 1
    • 84864275588 scopus 로고    scopus 로고
    • Arterial and venous thrombosis in adults
    • Kottke-Marchant K, ed, 1st ed. Northfield, IL: College of American Pathologists
    • Olson JD, Eby C. Arterial and venous thrombosis in adults. In: Kottke-Marchant K, ed. An algorithmic approach to hemostasis testing. 1st ed. Northfield, IL: College of American Pathologists, 2008:239-66.
    • (2008) An algorithmic approach to hemostasis testing , pp. 239-266
    • Olson, J.D.1    Eby, C.2
  • 2
    • 79251615145 scopus 로고    scopus 로고
    • Diagnostic algorithm for thrombophilia screening
    • Margetic S. Diagnostic algorithm for thrombophilia screening. Clin Chem Lab Med 2010;48(Suppl 1):S27-39.
    • (2010) Clin Chem Lab Med , vol.48 , Issue.SUPPL. 1
    • Margetic, S.1
  • 3
    • 0028108947 scopus 로고
    • Laboratory diagnosis of hemorrhagic and thrombotic disorders
    • Kottke-Marchant K. Laboratory diagnosis of hemorrhagic and thrombotic disorders. Hematol Oncol Clin North Am 1994;8:809-53.
    • (1994) Hematol Oncol Clin North Am , vol.8 , pp. 809-853
    • Kottke-Marchant, K.1
  • 4
    • 68249151034 scopus 로고    scopus 로고
    • Laboratory evaluation of hypercoagulability
    • Khor B, Van Cott EM. Laboratory evaluation of hypercoagulability. Clin Lab Med 2009;29:339-66.
    • (2009) Clin Lab Med , vol.29 , pp. 339-366
    • Khor, B.1    Van Cott, E.M.2
  • 5
    • 48549098855 scopus 로고    scopus 로고
    • Thrombophilia: common questions on laboratory assessment and management
    • Heit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 2007:127-35.
    • (2007) Hematology Am Soc Hematol Educ Program , pp. 127-135
    • Heit, J.A.1
  • 6
    • 77949821581 scopus 로고    scopus 로고
    • Clinical guidelines for testing for heritable thrombophilia
    • Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010;149:209-20.
    • (2010) Br J Haematol , vol.149 , pp. 209-220
    • Baglin, T.1    Gray, E.2    Greaves, M.3
  • 7
    • 84864273146 scopus 로고    scopus 로고
    • Laboratory diagnosis of inherited thrombophilia
    • Kottke-Marchant K, ed, 1st ed. Northfield, IL: College of American Pathologists
    • Eby C. Laboratory diagnosis of inherited thrombophilia. In: Kottke-Marchant K, ed. An algorithmic approach to hemostasis testing. 1st ed. Northfield, IL: College of American Pathologists, 2008:267-77.
    • (2008) An algorithmic approach to hemostasis testing , pp. 267-277
    • Eby, C.1
  • 8
    • 79958093890 scopus 로고    scopus 로고
    • Evidence-based approach to thrombophilia testing
    • Middeldorp S. Evidence-based approach to thrombophilia testing. J Thromb Thrombolysis 2011;31:275-81.
    • (2011) J Thromb Thrombolysis , vol.31 , pp. 275-281
    • Middeldorp, S.1
  • 9
    • 67149126682 scopus 로고    scopus 로고
    • Antiphospholipid antibodies
    • Kottke-Marchant K, ed, 1st ed. Northfield, IL: College of American Pathologists
    • Van Cott EM, Eby C. Antiphospholipid antibodies. In: Kottke-Marchant K, ed. An algorithmic approach to hemostasis testing. 1st ed. Northfield, IL: College of American Pathologists, 2008:295-304.
    • (2008) An algorithmic approach to hemostasis testing , pp. 295-304
    • Van Cott, E.M.1    Eby, C.2
  • 10
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4: 295-306.
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3
  • 11
    • 70350004861 scopus 로고    scopus 로고
    • Update of the guidelines for lupus anticoagulant detection
    • Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7:1737-40.
    • (2009) J Thromb Haemost , vol.7 , pp. 1737-1740
    • Pengo, V.1    Tripodi, A.2    Reber, G.3
  • 12
    • 0029953246 scopus 로고    scopus 로고
    • Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
    • Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996;100:530-6.
    • (1996) Am J Med , vol.100 , pp. 530-536
    • Finazzi, G.1    Brancaccio, V.2    Moia, M.3
  • 13
    • 0028810205 scopus 로고
    • Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH
    • Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
    • (1995) Thromb Haemost , vol.74 , pp. 1185-1190
    • Brandt, J.T.1    Triplett, D.A.2    Alving, B.3    Scharrer, I.4
  • 14
    • 7044236943 scopus 로고    scopus 로고
    • Anti-beta2-glycoprotein I antibodieswhen and how should they be measured?
    • Reber G, de Moerloose P. Anti-beta2-glycoprotein I antibodieswhen and how should they be measured? Thromb Res 2004;114: 527-31.
    • (2004) Thromb Res , vol.114 , pp. 527-531
    • Reber, G.1    de Moerloose, P.2
  • 15
    • 84885733441 scopus 로고    scopus 로고
    • Lupus anticoagulants, antiphospholipid antibodies, and antiphospholipid syndrome
    • Kottke-Marchant K, Davis BH, eds, West Sussex, UK: Wiley-Blackwell Publishing ltd
    • Nichols WL, Kottke-Marchant K, Ledford-Kraemer MR, Homburger HA, Cardel LK. Lupus anticoagulants, antiphospholipid antibodies, and antiphospholipid syndrome. In: Kottke-Marchant K, Davis BH, eds. Laboratory hematology practice. West Sussex, UK: Wiley-Blackwell Publishing ltd, 2012:509-25.
    • (2012) Laboratory hematology practice , pp. 509-525
    • Nichols, W.L.1    Kottke-Marchant, K.2    Ledford-Kraemer, M.R.3    Homburger, H.A.4    Cardel, L.K.5
  • 16
    • 84858283382 scopus 로고    scopus 로고
    • Guidelines on the investigation and management of antiphospholipid syndrome
    • Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47-58.
    • (2012) Br J Haematol , vol.157 , pp. 47-58
    • Keeling, D.1    Mackie, I.2    Moore, G.W.3    Greer, I.A.4    Greaves, M.5
  • 17
    • 84903533351 scopus 로고    scopus 로고
    • Laboratory testing for the lupus anticoagulant; Approved guideline
    • CLSI document H60. Wayne, PA: Clinical and Laboratory Standards Institute
    • Ledford-Kraemer MR, Moore GW, Bottenus R, et al, eds. Laboratory testing for the lupus anticoagulant; Approved guideline. CLSI document H60. Wayne, PA: Clinical and Laboratory Standards Institute, 2014.
    • (2014)
    • Ledford-Kraemer, M.R.1    Moore, G.W.2    Bottenus, R.3
  • 18
    • 84885712760 scopus 로고    scopus 로고
    • Thrombophilia: assays and interpretation
    • Kottke-Marchant K, Davis BH, eds, West Sussex, UK: Wiley-Blackwell Publishing ltd
    • Yohe S, Olson J. Thrombophilia: assays and interpretation. In: Kottke-Marchant K, Davis BH, eds. Laboratory hematology practice. West Sussex, UK: Wiley-Blackwell Publishing ltd, 2012:492-508.
    • (2012) Laboratory hematology practice , pp. 492-508
    • Yohe, S.1    Olson, J.2
  • 19
    • 60849125416 scopus 로고    scopus 로고
    • Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices
    • Moffat KA, Ledford-Kraemer MR, Plumhoff EA, et al. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost 2009;101:178-84.
    • (2009) Thromb Haemost , vol.101 , pp. 178-184
    • Moffat, K.A.1    Ledford-Kraemer, M.R.2    Plumhoff, E.A.3
  • 20
    • 0036881080 scopus 로고    scopus 로고
    • Antiphospholipid antibodies
    • Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002;126:1424-9.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1424-1429
    • Triplett, D.A.1
  • 21
    • 0141958839 scopus 로고    scopus 로고
    • Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
    • Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003;102:2717-23.
    • (2003) Blood , vol.102 , pp. 2717-2723
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 22
    • 0345689340 scopus 로고    scopus 로고
    • Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome
    • Marai I, Gilburd B, Blank M, Shoenfeld Y. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. Hum Antibodies 2003;12: 57-62.
    • (2003) Hum Antibodies , vol.12 , pp. 57-62
    • Marai, I.1    Gilburd, B.2    Blank, M.3    Shoenfeld, Y.4
  • 23
    • 0028931717 scopus 로고
    • High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
    • Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504-8.
    • (1995) Blood , vol.85 , pp. 1504-1508
    • Rosendaal, F.R.1    Koster, T.2    Vandenbroucke, J.P.3    Reitsma, P.H.4
  • 24
    • 0031023757 scopus 로고    scopus 로고
    • A single genetic origin for a common Caucasian risk factor for venous thrombosis
    • Zivelin A, Griffin JH, Xu X, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397-402.
    • (1997) Blood , vol.89 , pp. 397-402
    • Zivelin, A.1    Griffin, J.H.2    Xu, X.3
  • 25
    • 0030955080 scopus 로고    scopus 로고
    • Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening
    • Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997;277:1305-7.
    • (1997) JAMA , vol.277 , pp. 1305-1307
    • Ridker, P.M.1    Miletich, J.P.2    Hennekens, C.H.3    Buring, J.E.4
  • 26
  • 27
    • 0032520034 scopus 로고    scopus 로고
    • A novel mutation of Arg306 of factor V gene in Hong Kong Chinese
    • Chan WP, Lee CK, Kwong YL, Lam CK, Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 1998; 91:1135-9.
    • (1998) Blood , vol.91 , pp. 1135-1139
    • Chan, W.P.1    Lee, C.K.2    Kwong, Y.L.3    Lam, C.K.4    Liang, R.5
  • 28
    • 0033038853 scopus 로고    scopus 로고
    • The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations
    • Franco RF, Elion J, Tavella MH, Santos SE, Zago MA. The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations. Thromb Haemost 1999;81:312-3.
    • (1999) Thromb Haemost , vol.81 , pp. 312-313
    • Franco, R.F.1    Elion, J.2    Tavella, M.H.3    Santos, S.E.4    Zago, M.A.5
  • 29
    • 0037100417 scopus 로고    scopus 로고
    • Functional characterization of recombinant FV Hong Kong and FV Cambridge
    • Norstrom E, Thorelli E, Dahlback B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 2002;100:524-30.
    • (2002) Blood , vol.100 , pp. 524-530
    • Norstrom, E.1    Thorelli, E.2    Dahlback, B.3
  • 30
    • 0036881044 scopus 로고    scopus 로고
    • Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders
    • Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002;126:1304-18.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1304-1318
    • Press, R.D.1    Bauer, K.A.2    Kujovich, J.L.3    Heit, J.A.4
  • 31
    • 0034189760 scopus 로고    scopus 로고
    • A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay
    • Ledford M, Friedman KD, Hessner MJ, Moehlenkamp C, Williams TM, Larson RS. A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. J Mol Diagn 2000;2:97-104.
    • (2000) J Mol Diagn , vol.2 , pp. 97-104
    • Ledford, M.1    Friedman, K.D.2    Hessner, M.J.3    Moehlenkamp, C.4    Williams, T.M.5    Larson, R.S.6
  • 32
    • 84885766496 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in molecular diagnostics
    • Kottke-Marchant K, Davis BH, eds, West Sussex, UK: Wiley-Blackwell Publishing ltd
    • Murugesan G, Jans S, Han JY. Single nucleotide polymorphisms in molecular diagnostics. In: Kottke-Marchant K, Davis BH, eds. Laboratory hematology practice. West Sussex, UK: Wiley-Blackwell Publishing ltd, 2012:168-80.
    • (2012) Laboratory hematology practice , pp. 168-180
    • Murugesan, G.1    Jans, S.2    Han, J.Y.3
  • 33
    • 0036881490 scopus 로고    scopus 로고
    • Clinical and laboratory management of the prothrombin G20210A mutation
    • McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med 2002;126:1319-25.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1319-1325
    • McGlennen, R.C.1    Key, N.S.2
  • 34
    • 0031981017 scopus 로고    scopus 로고
    • Geographic distribution of the 20210 G to A prothrombin variant
    • Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
    • (1998) Thromb Haemost , vol.79 , pp. 706-708
    • Rosendaal, F.R.1    Doggen, C.J.2    Zivelin, A.3
  • 35
    • 84860625977 scopus 로고    scopus 로고
    • Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why
    • Ballard RB, Marques MB. Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why. Am J Clin Pathol 2012;137:553-60.
    • (2012) Am J Clin Pathol , vol.137 , pp. 553-560
    • Ballard, R.B.1    Marques, M.B.2
  • 36
    • 0029850530 scopus 로고    scopus 로고
    • A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
    • Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
    • (1996) Blood , vol.88 , pp. 3698-3703
    • Poort, S.R.1    Rosendaal, F.R.2    Reitsma, P.H.3    Bertina, R.M.4
  • 37
    • 77953077082 scopus 로고    scopus 로고
    • Laboratory tests for protein C deficiency
    • Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol 2010;85:440-2.
    • (2010) Am J Hematol , vol.85 , pp. 440-442
    • Khor, B.1    Van Cott, E.M.2
  • 38
    • 0036881556 scopus 로고    scopus 로고
    • Laboratory evaluation of hypercoagulability with venous or arterial thrombosis
    • Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med 2002;126:1281-95.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1281-1295
    • Van Cott, E.M.1    Laposata, M.2    Prins, M.H.3
  • 39
    • 42449084553 scopus 로고    scopus 로고
    • Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
    • Maurissen LF, Thomassen MC, Nicolaes GA, et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood 2008;111:3034-41.
    • (2008) Blood , vol.111 , pp. 3034-3041
    • Maurissen, L.F.1    Thomassen, M.C.2    Nicolaes, G.A.3
  • 41
    • 0034994094 scopus 로고    scopus 로고
    • A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state
    • Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001;113:636-41.
    • (2001) Br J Haematol , vol.113 , pp. 636-641
    • Dykes, A.C.1    Walker, I.D.2    McMahon, A.D.3    Islam, S.I.4    Tait, R.C.5
  • 42
    • 0030001877 scopus 로고    scopus 로고
    • New direct assay of free protein S antigen applied to diagnosis of protein S deficiency
    • Aillaud MF, Pouymayou K, Brunet D, et al. New direct assay of free protein S antigen applied to diagnosis of protein S deficiency. Thromb Haemost 1996;75:283-5.
    • (1996) Thromb Haemost , vol.75 , pp. 283-285
    • Aillaud, M.F.1    Pouymayou, K.2    Brunet, D.3
  • 43
    • 55249124089 scopus 로고    scopus 로고
    • Regulation of coagulation by protein S
    • Castoldi E, Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hematol 2008;15:529-36.
    • (2008) Curr Opin Hematol , vol.15 , pp. 529-536
    • Castoldi, E.1    Hackeng, T.M.2
  • 44
    • 46749102183 scopus 로고    scopus 로고
    • PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations
    • Ten Kate MK, Platteel M, Mulder R, et al. PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations. Hum Mutat 2008;29: 939-47.
    • (2008) Hum Mutat , vol.29 , pp. 939-947
    • Ten Kate, M.K.1    Platteel, M.2    Mulder, R.3
  • 46
    • 19944433631 scopus 로고    scopus 로고
    • Familial thrombophilia and lifetime risk of venous thrombosis
    • Vossen CY, Conard J, Fontcuberta J, et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004;2:1526-32.
    • (2004) J Thromb Haemost , vol.2 , pp. 1526-1532
    • Vossen, C.Y.1    Conard, J.2    Fontcuberta, J.3
  • 47
    • 84903517492 scopus 로고    scopus 로고
    • Antithrombin deficiency
    • Gulati G, Filicko-O'Hara J, Krause JR, eds, Chicago, IL: American Society for Clinical Pathology Press
    • Rogers HJ, Kottke-Marchant K. Antithrombin deficiency. In: Gulati G, Filicko-O'Hara J, Krause JR, eds. Case studies in hematology and coagulation. Chicago, IL: American Society for Clinical Pathology Press, 2012:416-8.
    • (2012) Case studies in hematology and coagulation , pp. 416-418
    • Rogers, H.J.1    Kottke-Marchant, K.2
  • 48
    • 0036881507 scopus 로고    scopus 로고
    • Antithrombin deficiency: issues in laboratory diagnosis
    • Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002;126:1326-36.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1326-1336
    • Kottke-Marchant, K.1    Duncan, A.2
  • 49
    • 33745289474 scopus 로고    scopus 로고
    • Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene
    • Picard V, Nowak-Gottl U, Biron-Andreani C, et al. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat 2006;27:600.
    • (2006) Hum Mutat , vol.27 , pp. 600
    • Picard, V.1    Nowak-Gottl, U.2    Biron-Andreani, C.3
  • 50
    • 78649524580 scopus 로고    scopus 로고
    • Laboratory tests for antithrombin deficiency
    • Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. Am J Hematol 2010;85:947-50.
    • (2010) Am J Hematol , vol.85 , pp. 947-950
    • Khor, B.1    Van Cott, E.M.2
  • 53
    • 34250333053 scopus 로고    scopus 로고
    • Hyperhomocysteinemia and thrombosis: an overview
    • Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 2007;131:872-84.
    • (2007) Arch Pathol Lab Med , vol.131 , pp. 872-884
    • Eldibany, M.M.1    Caprini, J.A.2
  • 54
    • 0037633079 scopus 로고    scopus 로고
    • Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies
    • Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002;32:51-8.
    • (2002) Pathophysiol Haemost Thromb , vol.32 , pp. 51-58
    • Ray, J.G.1    Shmorgun, D.2    Chan, W.S.3
  • 55
    • 20444445722 scopus 로고    scopus 로고
    • Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies
    • Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-9.
    • (2005) J Thromb Haemost , vol.3 , pp. 292-299
    • Den Heijer, M.1    Lewington, S.2    Clarke, R.3
  • 56
    • 84873540085 scopus 로고    scopus 로고
    • ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing
    • Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 2013;15:153-6.
    • (2013) Genet Med , vol.15 , pp. 153-156
    • Hickey, S.E.1    Curry, C.J.2    Toriello, H.V.3
  • 57
    • 0033965871 scopus 로고    scopus 로고
    • Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response
    • O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2000;83:10-3.
    • (2000) Thromb Haemost , vol.83 , pp. 10-13
    • O'Donnell, J.1    Mumford, A.D.2    Manning, R.A.3    Laffan, M.4
  • 58
    • 0038373832 scopus 로고    scopus 로고
    • High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly
    • Oger E, Lacut K, Van Dreden P, et al. High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica 2003;88:465-9.
    • (2003) Haematologica , vol.88 , pp. 465-469
    • Oger, E.1    Lacut, K.2    Van Dreden, P.3
  • 59
    • 79957724437 scopus 로고    scopus 로고
    • High plasma level of factor VIII: an important risk factor for venous thromboembolism
    • Ota S, Yamada N, Ogihara Y, et al. High plasma level of factor VIII: an important risk factor for venous thromboembolism. Circ J 2011;75:1472-5.
    • (2011) Circ J , vol.75 , pp. 1472-1475
    • Ota, S.1    Yamada, N.2    Ogihara, Y.3
  • 61
    • 0033983988 scopus 로고    scopus 로고
    • High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism
    • Kraaijenhagen RA, in't Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5-9.
    • (2000) Thromb Haemost , vol.83 , pp. 5-9
    • Kraaijenhagen, R.A.1    In't Anker, P.S.2    Koopman, M.M.3
  • 62
    • 0034680013 scopus 로고    scopus 로고
    • High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
    • Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-62.
    • (2000) N Engl J Med , vol.343 , pp. 457-462
    • Kyrle, P.A.1    Minar, E.2    Hirschl, M.3
  • 63
    • 0038141763 scopus 로고    scopus 로고
    • High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies
    • Benjaber K, Constans J, Cougnard A, Salmi LR. High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies. Rev Med Interne 2003;24:366-71.
    • (2003) Rev Med Interne , vol.24 , pp. 366-371
    • Benjaber, K.1    Constans, J.2    Cougnard, A.3    Salmi, L.R.4
  • 64
    • 0028877613 scopus 로고
    • Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen
    • Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995;73:151-61.
    • (1995) Thromb Haemost , vol.73 , pp. 151-161
    • Haverkate, F.1    Samama, M.2
  • 66
    • 0036880584 scopus 로고    scopus 로고
    • Dysfibrinogenemia and thrombosis
    • Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 2002;126:1387-90.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1387-1390
    • Hayes, T.1
  • 67
    • 56749125053 scopus 로고    scopus 로고
    • Laboratory testing for fibrinogen abnormalities
    • Verhovsek M, Moffat KA, Hayward CP. Laboratory testing for fibrinogen abnormalities. Am J Hematol 2008;83:928-31.
    • (2008) Am J Hematol , vol.83 , pp. 928-931
    • Verhovsek, M.1    Moffat, K.A.2    Hayward, C.P.3
  • 68
    • 84881474743 scopus 로고    scopus 로고
    • Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations
    • Mani H, Kasper A, Lindhoff-Last E. Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations. J Thromb Thrombolysis 2013;36:187-94.
    • (2013) J Thromb Thrombolysis , vol.36 , pp. 187-194
    • Mani, H.1    Kasper, A.2    Lindhoff-Last, E.3
  • 69
    • 84876459325 scopus 로고    scopus 로고
    • Novel anticoagulants and laboratory testing
    • Eby C. Novel anticoagulants and laboratory testing. Int J Lab Hematol 2013;35:262-8.
    • (2013) Int J Lab Hematol , vol.35 , pp. 262-268
    • Eby, C.1
  • 70
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 71
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 72
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 73
    • 84878260361 scopus 로고    scopus 로고
    • Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
    • Steiner T, Bohm M, Dichgans M, et al. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol 2013;102:399-412.
    • (2013) Clin Res Cardiol , vol.102 , pp. 399-412
    • Steiner, T.1    Bohm, M.2    Dichgans, M.3
  • 74
    • 84876192857 scopus 로고    scopus 로고
    • Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
    • Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W. Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2013;11:756-60.
    • (2013) J Thromb Haemost , vol.11 , pp. 756-760
    • Baglin, T.1    Hillarp, A.2    Tripodi, A.3    Elalamy, I.4    Buller, H.5    Ageno, W.6
  • 75
    • 84862146631 scopus 로고    scopus 로고
    • Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban
    • Harenberg J, Marx S, Weiss C, Kramer R, Samama M, Schulman S. Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban. J Thromb Haemost 2012;10:1433-6.
    • (2012) J Thromb Haemost , vol.10 , pp. 1433-1436
    • Harenberg, J.1    Marx, S.2    Weiss, C.3    Kramer, R.4    Samama, M.5    Schulman, S.6
  • 76
    • 84901191606 scopus 로고    scopus 로고
    • Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH
    • Harenberg J, Du S, Weiss C, Kramer R, Hoppensteadt D, Walenga J. Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH. J Thromb Haemost 2014;12:801-4.
    • (2014) J Thromb Haemost , vol.12 , pp. 801-804
    • Harenberg, J.1    Du, S.2    Weiss, C.3    Kramer, R.4    Hoppensteadt, D.5    Walenga, J.6
  • 77
    • 84898678739 scopus 로고    scopus 로고
    • Interpretation of coagulation test results under direct oral anticoagulants
    • Mani H. Interpretation of coagulation test results under direct oral anticoagulants. Int J Lab Hematol 2014;36:261-8.
    • (2014) Int J Lab Hematol , vol.36 , pp. 261-268
    • Mani, H.1
  • 78
    • 10844233894 scopus 로고    scopus 로고
    • The ecarin clotting time, a universal method to quantify direct thrombin inhibitors
    • Nowak G. The ecarin clotting time, a universal method to quantify direct thrombin inhibitors. Pathophysiol Haemost Thromb 2003;33:173-83.
    • (2003) Pathophysiol Haemost Thromb , vol.33 , pp. 173-183
    • Nowak, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.